Home
Immunology Focus Group Newsletter
November 2018, Number 1
About Us Speakers Investigators Sponsors Opportunities Resources Forum Contact Us
IFG Lecture - November 2018
Thomas A. Wynn
NOV
6
Lunch for lecture audience: 12 pm
Lecture:12:15 - 1:30 pm

Wertz Auditorium (Hudson Webber Cancer Research Center, 2nd floor)
4100 John R., Detroit, MI 48201

Jointly Hosted by:
Department of Biochemistry, Microbiology and Immunology
Department of Oncology, Barbara Ann Karmanos Cancer Institute
Immunology Focus Group

Supported by:
Barbara Ann Karmanos Cancer Institute
Office of the Vice President for Research, Wayne State University
Henry Ford Health System

Role of Type 2 Cytokine Signaling in Tissue Regeneration and Fibrosis

Thomas Wynn, Ph.D.
Vice President of Discovery
Pfizer

Hosts: Matthew Fountain, MS
Department of Biochemistry, Microbiology and Immunology, Barbara Ann Karmanos Cancer Institute, Wayne State University
Dr. Wynn joined Pfizer in 2017 to lead the Discovery effort in the Inflammation and Immunology Research Unit in Cambridge, MA. Prior to joining Pfizer, he was a Senior Investigator and Chief of the Immunopathogenesis Section of the Laboratory of Parasitic Disease, in the National Institute of Allergy and Infectious Diseases, NIH in Bethesda, Maryland. Dr. Wynn received his Ph.D. from the Department of Medical Microbiology and Immunology at the University of Wisconsin at Madison. He has published over 200 research papers, reviews, and book chapters in many prestigious journals including Nature, Science, and Nature Immunology, and have made important contributions to our understanding of the role of cytokines and growth factors in the progression and resolution of chronic inflammation, tissue regeneration, and fibrosis. At Pfizer, Dr. Wynn is leading the discovery efforts in the areas of immune tolerance, epithelial cell biology, immunometabolism, innate immunity, and fibrosis.

Dr. Wynn is a Fellow of the American Academy of Microbiology, and has won many prestigious international awards. For the past three years, he has been included on Thomson Reuters’ list of Highly Cited Researchers.

Copyright © 2013-2018, WSU, KCI, HFHS Immunology Focus Group